Anbio Biotechnology
NNNN
$6.57
$0.192.98%
NASDAQ
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 60.16% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 60.16% | |||
| Cost of Revenue | 0.00% | -7.16% | |||
| Gross Profit | 0.00% | 150.07% | |||
| SG&A Expenses | 0.00% | -79.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | -27.68% | |||
| Operating Income | 0.00% | 566.86% | |||
| Income Before Tax | 0.00% | 390.67% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.00% | 390.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | 390.67% | |||
| EBIT | 0.00% | 566.86% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 0.00% | 1,534.62% | |||
| Normalized Basic EPS | 0.00% | 1,562.50% | |||
| EPS Diluted | 0.00% | 1,534.62% | |||
| Normalized Diluted EPS | 0.00% | 1,562.50% | |||
| Average Basic Shares Outstanding | 0.00% | -70.28% | |||
| Average Diluted Shares Outstanding | 0.00% | -70.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||